Squamous differentiation in surgically resected malignant pleural mesothelioma with neoadjuvant chemotherapy

被引:2
|
作者
Yotsukura, Masaya [1 ]
Motoi, Noriko [2 ,3 ]
Yoshida, Akihiko [2 ]
Yoshida, Yukihiro [1 ]
Nakagawa, Kazuo [1 ]
Watanabe, Shun-ichi [1 ]
机构
[1] Natl Canc Ctr, Dept Thorac Surg, Tokyo, Japan
[2] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo, Japan
[3] Saitama Canc Ctr, Dept Pathol, Saitama, Japan
关键词
immunohistochemistry; mesothelioma; squamous cell; surgical treatment; CELL CARCINOMA; CYTOKERATIN; 5/6; EXPRESSION; LUNG; ADENOCARCINOMA; DIAGNOSIS; BAP1; RARE;
D O I
10.1111/pin.13143
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We describe a rare case of malignant pleural mesothelioma (MPM) that developed squamous differentiation. MPM can present various patterns of histology, but squamous differentiation has not been reported in any surgically resected cases to date. The patient was a 50-year-old female without smoking habit who had right MPM and underwent pleurectomy/decortication after chemotherapy. Pathological examination of the surgical specimen found that the MPM contained squamous cancer cells with apparent keratinization close to the tubulopapillary epithelioid tumor cells. Squamous differentiation was recognized close to the mesothelial proliferation, and the topographical origin of the tumor could not be recognized in the lung. The tubulopapillary tumor cells were positive for cytokeratin 5/6, Wilms tumor-1, and calretinin, and negative for thyroid transcription factor-1 (TTF-1), claudin-4, and p40. Squamous cells were positive for cytokeratin 5/6 and p40, and negative for Wilms tumor-1, calretinin, and TTF-1. Loss of BRCA1 associated protein-1 (BAP1) was observed in both the tubulopapillary and squamous tumor cells. Based on the loss of BAP1 and no history of smoking, we diagnosed this case as a rare differentiation of biphasic-type MPM into squamous cell carcinoma.
引用
收藏
页码:692 / 696
页数:5
相关论文
共 50 条
  • [11] Chemotherapy of malignant pleural mesothelioma
    Berghmans, T.
    Brechot, J. -M.
    Robinet, G.
    Guigay, J.
    Morere, P.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (04) : S57 - S70
  • [12] Chemotherapy of malignant pleural mesothelioma
    Bertino, Pietro
    Carbone, Michele
    Pass, Harvey
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (01) : 99 - 107
  • [13] Chemotherapy for Malignant Pleural Mesothelioma
    Linda L Garland
    [J]. Current Treatment Options in Oncology, 2011, 12 : 181 - 188
  • [14] A Model for Approaching Pathologic Assessment of Treatment Response to Neoadjuvant Chemotherapy in Resected Pleural Mesothelioma
    Aly, Rania G.
    Offin, Michael
    Tan, Kay See
    Bodd, Francis
    Adusumilli, Prasad
    Travis, William
    Zauderer, Marjorie
    Sauter, Jennifer
    [J]. LABORATORY INVESTIGATION, 2024, 104 (03) : S1895 - S1895
  • [15] Neoadjuvant Compared to Adjuvant Chemotherapy as Part of Trimodality Therapy for Malignant Pleural Mesothelioma
    Osborn, V. W.
    Lee, A.
    Sheth, N.
    Lederman, A. J.
    Nwokedi, E. C.
    Safdieh, J., Jr.
    Schreiber, D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E664 - E665
  • [16] Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma: Is it safe? Reply
    Weder, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) : 655 - 655
  • [17] Malignant mesothelioma with squamous differentiation
    Tanaka, Hiroyuki
    Akiyama, Yutaka
    Kitamura, Akiko
    Matsumoto, Nobuhiro
    Tomita, Masaki
    Kataoka, Hiroaki
    [J]. HISTOPATHOLOGY, 2018, 72 (07) : 1216 - 1220
  • [18] CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA - CAMEO
    JETT, JR
    EAGAN, RT
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (04): : 82 - 82
  • [19] Chemotherapy in malignant pleural mesothelioma: A review
    Ong, ST
    Vogelzang, NJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 1007 - 1017
  • [20] Neoadjuvant and Intrapleural Therapies for Malignant Pleural Mesothelioma
    Tsao, Anne S.
    Mehran, Reza
    Roth, Jack A.
    [J]. CLINICAL LUNG CANCER, 2009, 10 (01) : 36 - 41